Compositions and methods are provided for mitigating the effects of alcohol by delaying alcohol absorption and/or reducing blood alcohol concentration, and/or for delaying gastric emptying.

Provided is a composition for relieving a hangover including as its active ingredients Corylus heterophylla Fisher nut extract, Alnus japonica Steud. stem extract and Sorbus commixta fruit extract. It is verified the composition for relieving a hangover according to the present disclosure reduces blood alcohol concentration more significantly than the composition for relieving a hangover including as its active ingredients Alnus japonica Steud. extract and Sorbus commixta extract as disclosed in Korean Patent Registration No. 181168 in in vivo tests (including animal testing and human experiment) and that has effects of considerably alleviating various hangover symptoms.

Disclosed is a composition containing a licorice extract comprising glycyrrhizin and liquiritin at a content ratio of 1.5 to 1.8:1, obtained by performing extraction on licorice, adding an excipient and performing spray drying. The composition containing the licorice extract can be efficiently used as a pharmaceutical composition for the prevention or treatment of liver disease or a food composition for the improvement of liver function in the pharmaceutical and food industry fields.

Disclosed is a composition containing a licorice extract comprising glycyrrhizin and liquiritin at a content ratio of 1.5 to 1.8:1, obtained by performing extraction on licorice, adding an excipient and performing spray drying. The composition containing the licorice extract can be efficiently used as a pharmaceutical composition for the prevention or treatment of liver disease or a food composition for the improvement of liver function in the pharmaceutical and food industry fields.

A method and apparatus for modifying a behavior of a user are disclosed. For example, the method determines a baseline of a behavior to be modified for a user, the baseline comprising at least one triggering event that is established for the behavior to be modified and at least one action to be taken when the at least one triggering event is detected, detects the at least one triggering event that is established for the behavior to be modified for the user, identifies the at least one action to be performed when the at least one triggering event is detected, and performs the at least action that is identified.

Compositions and methods for treating a subject for a substance-abuse related disease or disorder are disclosed. The substance-abuse related disease or disorder can be an alcohol-related, an opioid-related, a cocaine-related, an amphetamine-related, a marijuana related, hallucinogen-related, barbiturate-related, benzodiazepine-related, or VOC-related disease or disorder. The composition for treating the substance-abuse related disease or disorder can be selected from a microbiota transplant, a particular diet or diet ingredient, a probiotic, or a combination thereof. In some embodiments, the composition can be a fecal transplant. The fecal transplant can be administered in a therapeutically effective amount to increase the amount of gastrointestinal microbiota when consumed by the subject. The methods described herein can further include administering a therapeutic agent in combination with the composition that modulates the gut microbiota.

Compositions and methods for treating a subject for a substance-abuse related disease or disorder are disclosed. The substance-abuse related disease or disorder can be an alcohol-related, an opioid-related, a cocaine-related, an amphetamine-related, a marijuana related, hallucinogen-related, barbiturate-related, benzodiazepine-related, or VOC-related disease or disorder. The composition for treating the substance-abuse related disease or disorder can be selected from a microbiota transplant, a particular diet or diet ingredient, a probiotic, or a combination thereof. In some embodiments, the composition can be a fecal transplant. The fecal transplant can be administered in a therapeutically effective amount to increase the amount of gastrointestinal microbiota when consumed by the subject. The methods described herein can further include administering a therapeutic agent in combination with the composition that modulates the gut microbiota.

A process for making an anti-intoxication food supplement composition, said process comprising the steps of combining sulfuric acid with water, such that the volume ratio of sulfuric acid to distilled water lies in the range 1:1 to 1:5, and with a sulfate salt at a ratio of 10-40% volume, forming a first mixture, combining the first mixture in a vessel at a pressure above atmospheric pressure, allowing an exothermic reaction to heat up the mixture forming a reacted first mixture, cooling the reacted first mixture, adding a compound containing metal ions to the reacted first mixture, to form a second mixture, diluting the second mixture with water and adding at least one sweetener, flavoring agent, micro nutrient, macro nutrient, or food additive such as a vitamin to provide an anti-intoxication food supplement composition.

The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use.

##STR00001##

The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.

The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use.

##STR00001##

The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.